211 related articles for article (PubMed ID: 1901083)
1. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis.
Christensen RD; Brown MS; Hall DC; Lassiter HA; Hill HR
J Pediatr; 1991 Apr; 118(4 Pt 1):606-14. PubMed ID: 1901083
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis.
Cairo MS; Worcester CC; Rucker RW; Hanten S; Amlie RN; Sender L; Hicks DA
J Pediatr; 1992 Feb; 120(2 Pt 1):281-5. PubMed ID: 1735830
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immune globulin therapy for early-onset sepsis in premature neonates.
Weisman LE; Stoll BJ; Kueser TJ; Rubio TT; Frank CG; Heiman HS; Subramanian KN; Hankins CT; Anthony BF; Cruess DF
J Pediatr; 1992 Sep; 121(3):434-43. PubMed ID: 1517923
[TBL] [Abstract][Full Text] [Related]
4. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin.
Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ
J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates.
Weisman LE; Stoll BJ; Kueser TJ; Rubio TT; Frank CG; Heiman HS; Subramanian KN; Hankins CT; Cruess DF; Hemming VG
J Pediatr; 1994 Dec; 125(6 Pt 1):922-30. PubMed ID: 7996367
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled investigation of the safety of intravenous immune globulin administration to preterm neonates.
Christensen RD; Hardman T; Thornton J; Hill HR
J Perinatol; 1989 Jun; 9(2):126-30. PubMed ID: 2738720
[TBL] [Abstract][Full Text] [Related]
8. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.
Weisman LE; Anthony BF; Hemming VG; Fischer GW
J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics.
Fischer GW; Weisman LE
Scand J Infect Dis Suppl; 1990; 73():17-21. PubMed ID: 2128662
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous immunoglobulin G on neutrophil kinetics during experimental group B streptococcal infection in neonatal rats.
Harper TE; Christensen RD; Rothstein G; Hill HR
Rev Infect Dis; 1986; 8 Suppl 4():S401-8. PubMed ID: 3092307
[TBL] [Abstract][Full Text] [Related]
11. Determination of slime-producing S. epidermidis specific antibodies in human immunoglobulin preparations and blood sera by an enzyme immunoassay: correlation of antibody titers with opsonic activity and application to preterm neonates.
Lamari F; Anastassiou ED; Stamokosta E; Photopoulos S; Xanthou M; Dimitracopoulos G; Karamanos NK
J Pharm Biomed Anal; 2000 Aug; 23(2-3):363-74. PubMed ID: 10933528
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils.
Christensen RD; Rothstein G; Anstall HB; Bybee B
Pediatrics; 1982 Jul; 70(1):1-6. PubMed ID: 7088606
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
[TBL] [Abstract][Full Text] [Related]
14. Circulating and storage neutrophils in septic neonatal rats treated with immune globulin.
Redd H; Christensen RD; Fischer GW
J Infect Dis; 1988 Apr; 157(4):705-12. PubMed ID: 2831286
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin in the prevention and treatment of neonatal bacterial sepsis.
Lassiter HA
Adv Pediatr; 1992; 39():71-99. PubMed ID: 1442320
[TBL] [Abstract][Full Text] [Related]
16. Potential use of intravenous immune globulin for group B streptococcal infection.
Baker CJ; Noya FJ
Rev Infect Dis; 1990; 12 Suppl 4():S476-82. PubMed ID: 2194272
[TBL] [Abstract][Full Text] [Related]
17. Opsonic activity in serum from septic infants treated with intravenous immunoglobulin.
Maródi L; Kalmár A; Szabó I
Arch Dis Child; 1989 Apr; 64(4):530-4. PubMed ID: 2751327
[TBL] [Abstract][Full Text] [Related]
18. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
Hill HR; Augustine NH; Shigeoka AO
Am J Med; 1984 Mar; 76(3A):61-6. PubMed ID: 6424458
[TBL] [Abstract][Full Text] [Related]
19. Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis.
Cairo MS; Worcester C; Rucker R; Bennetts GA; Amlie R; Perkin R; Anas N; Hicks D
J Pediatr; 1987 Jun; 110(6):935-41. PubMed ID: 3585610
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1.
Lassiter HA; Robinson TW; Brown MS; Hall DC; Hill HR; Christensen RD
J Perinatol; 1996; 16(5):346-51. PubMed ID: 8915932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
